FY March 2026 Financial Summary [IFRS] (Consolidated)

Overview of Financial Results

For the fiscal year ending March 2026, consolidated revenue was JPY 947,749 million (9.4% Year-over-Year increase), profit before tax was JPY 327,668 million (26.0% Year-over-Year increase), net income was JPY 251,451 million (24.6% Year-over-Year increase), and net income attributable to owners of parent was JPY 253,085 million (25.2% Year-over-Year increase). Both the Life Care and Information & Communication segments achieved year-on-year growth in revenue and profit, notably with increased demand for semiconductor mask blanks and photo masks for FPDs in the Information & Communication segment contributing to results. Despite foreign exchange impacts, a one-time gain was recorded from the revision of a previously recorded purchase price for a joint venture related to cataract intraocular lenses, driving significant profit growth.

Capital Policy and Dividends

The number of shares outstanding at period-end was 338,414,320 shares, down from the previous year due to treasury stock acquisition and cancellation. A cancellation of 3,576,300 shares (1.07% of total issued shares) is scheduled for May 15, 2026. The annual dividend is planned at JPY 295 (interim dividend JPY 125, year-end dividend JPY 170), with a dividend payout ratio of 39.7%. Going forward, the company will focus on improving capital efficiency by primarily acquiring treasury stock and gradually releasing surplus funds while aiming to optimize cash and deposits levels.